K

L

Luma Group

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Series B

C
Character Biosciences

Precision medicine • Drug development

Character Biosciences is a precision medicine company focused on developing therapies for degenerative eye diseases, particularly age-related macular degeneration.

Series B
$93M
03/25/2025
Article
A
ArsenalBio

Programmable cell therapy • Clinical development

Westlake Village BioPartners logo
T. Rowe Price Associates logo
SoftBank logo
Rock Springs Capital logo

Arsenal Biosciences, Inc. is a clinical-stage company developing programmable T cell therapies for solid tumor cancers using a computationally driven approach.

Series C
$325M
09/04/2024
Article
R
ROME Therapeutics

Biotechnology • Autoimmune Diseases

Section 32 logo
Sanofi Ventures logo
Raycap logo
Mirae Asset Capital logo

ROME Therapeutics is a biotechnology company that develops breakthrough medicines for serious diseases, with a focus on an inhibitor of LINE-1 reverse transcriptase for autoimmune diseases, using their proprietary data science platform to identify active repeat elements and assess their roles in disease.

Series B
$72M
09/12/2023
Article